Home › Cancer (all types) › NCT07471958

Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* 18 years of age or older
* Speak and understand English
* Meet current National Comprehensive Cancer Network (NCCN) or other national guidelines for germline genetic testing or are interested in genetic counseling based on personal or family history of cancer. Patients with prior genetic testing are eligible if they meet criteria for updated testing, or if post-test genetic counseling services are requested.

Exclusion Criteria:

* Communication difficulties such as:
* Uncorrected or uncompensated hearing and/or vision impairment. Patients who can successfully use clinical assistance devices are not excluded.
* Uncorrected or uncompensated speech defects. Patients who can successfully use clinical assistance devices are not excluded.
* Uncontrolled psychiatric/mental condition or severe physical, neurological or cognitive deficits rendering individual unable to understand study goals and tasks

About the study

The purpose of the study is to understand patient interest in telehealth and digital tools for pre-test genetic education and/or disclosure of genetic test results. Participants will receive telehealth genetic counseling in the home and may be offered various digital tools to help with the counseling and testing process. These are optional and participants can still speak with a genetic counselor if they wish.

Sponsor: Abramson Cancer Center at Penn Medicine · Participants: 360 · Started: Sep 2, 2025

Contact the study team

• Angela Bradbury, MD · Phone: 215-615-3341
• Kelsey Karpink · Phone: 215-662-3531

Official record on ClinicalTrials.gov — NCT07471958

Locations in the U.S.

Conditions

• Cancer (all types)

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.